mendelian randomization |
28 |
epidemiology |
22 |
hypertension |
21 |
cohort studies |
19 |
cardiovascular diseases |
15 |
type 2 diabetes |
15 |
chinese |
14 |
public health |
14 |
secondary prevention |
13 |
vitamin d |
13 |
ischemic stroke |
12 |
mendelian randomization analysis |
12 |
myocardial infarction |
12 |
recurrence |
12 |
diabetes |
11 |
paediatrics |
11 |
statistics & research methods |
11 |
stroke |
11 |
testosterone |
11 |
uk biobank |
11 |
exome chip |
10 |
blood pressure |
9 |
cholesterol |
9 |
estrogen |
9 |
menarche |
9 |
odds ratio |
9 |
cardiovascular disease |
8 |
coronary heart disease |
8 |
covid-19 |
8 |
diabetes mellitus |
8 |
hand strength |
8 |
instrumental variable analysis |
8 |
length/height |
8 |
sleep duration |
8 |
weight |
8 |
alzheimer’s disease |
7 |
bronchopulmonary dysplasia |
7 |
cancer |
7 |
genetic susceptibility |
7 |
genetics |
7 |
hba1c |
7 |
infant |
7 |
lung function |
7 |
premature |
7 |
supplemental oxygen |
7 |
adolescents |
6 |
birth weight |
6 |
body mass index |
6 |
cardiovascular risk factors |
6 |
china |
6 |
cognitive function |
6 |
drug-target mendelian randomization |
6 |
fats |
6 |
genetic risk |
6 |
genome-wide association studies |
6 |
glycated hemoglobin |
6 |
grip strength |
6 |
hemoglobin |
6 |
hmgcr inhibitors |
6 |
inflammation |
6 |
lipids |
6 |
liver function |
6 |
mendelian randomisation |
6 |
pcsk9 inhibitors |
6 |
safety |
6 |
systematic review |
6 |
twin status |
6 |
adolescent |
5 |
aldehyde dehydrogenase 2 |
5 |
asthma |
5 |
bmi |
5 |
breast feeding |
5 |
cognition |
5 |
cognition - physiology |
5 |
dementia |
5 |
diet |
5 |
estrogens - physiology |
5 |
fasting plasma glucose |
5 |
menarcheal age |
5 |
menopause |
5 |
postmenopause - blood - psychology |
5 |
puberty |
5 |
reproductive history |
5 |
risk factors |
5 |
women |
5 |
active transport |
4 |
adiposity |
4 |
adolescence |
4 |
adult |
4 |
alcohol |
4 |
alcohol drinking - genetics |
4 |
aldehyde dehydrogenase - genetics - metabolism |
4 |
ampk |
4 |
androgen |
4 |
asian continental ancestry group - genetics |
4 |
birth cohort |
4 |
cardiovascular |
4 |
cardiovascular disease risk factors |
4 |
causal effect |
4 |
children |
4 |
chinese men |
4 |
coronary artery disease |
4 |
depressive symptoms |
4 |
electrocardiogram |
4 |
g6pd deficiency |
4 |
gene |
4 |
hematocrit |
4 |
instrumental variable estimate |
4 |
ischemic heart disease |
4 |
mediation |
4 |
metabolomics |
4 |
metformin |
4 |
metformin targets |
4 |
multiple births |
4 |
polymorphism, single nucleotide |
4 |
southern chinese |
4 |
statins |
4 |
sugar-sweetened beverages |
4 |
treatment |
4 |
abdominal obesity |
3 |
ace2 |
3 |
body composition |
3 |
breast cancer screening |
3 |
cancers |
3 |
cardiometabolic risk markers |
3 |
cardiovascular risk factor |
3 |
causal inference |
3 |
competing risk |
3 |
computer use |
3 |
disease aetiology |
3 |
ferritin |
3 |
fgf23 |
3 |
genetic epidemiology |
3 |
glucose |
3 |
glycaemic traits |
3 |
glycemic traits |
3 |
growth |
3 |
growth differentiation factor 15 |
3 |
healthy lifestyle |
3 |
hepcidin |
3 |
insulin |
3 |
iron |
3 |
kidney disease |
3 |
korean women |
3 |
lean mass |
3 |
lifestyle |
3 |
linearity |
3 |
liver cirrhosis |
3 |
liver iron |
3 |
liver steatosis |
3 |
longevity |
3 |
mendelian randomization studies |
3 |
muscle |
3 |
older adults |
3 |
physical activity |
3 |
polygenic risk scores |
3 |
psychometric properties |
3 |
reporting guideline |
3 |
reporting quality |
3 |
sedentary behavior |
3 |
selection bias |
3 |
sex hormones |
3 |
shared etiology |
3 |
tv viewing |
3 |
type 2 diabetes mellitus |
3 |
venous thromboembolism |
3 |
adiponectin |
2 |
amyloid |
2 |
arachidonic acid |
2 |
atrial fibrillation |
2 |
bi-directional |
2 |
brain expression |
2 |
cardiometabolic diseases |
2 |
chronic obstructive pulmonary disease |
2 |
coagulation |
2 |
cohort study |
2 |
drinking of alcoholic beverages - china - hong kong. |
2 |
drinking of alcoholic beverages - health aspects. |
2 |
electronic healthcare records |
2 |
general population |
2 |
hba1c hemoglobin |
2 |
heart failure |
2 |
lipid |
2 |
mediation analysis |
2 |
mitochondrial function |
2 |
mortality |
2 |
non-diabetic individuals |
2 |
obesity |
2 |
observational analysis |
2 |
prostate cancer |
2 |
sglt2 inhibition |
2 |
smoking |
2 |
sodium |
2 |
soy product intake |
2 |
tau |
2 |
vascular endothelial growth factor |
2 |
adverse care experiences |
1 |
all-cause mortality |
1 |
cause-specific mortality |
1 |
childhood socio-economic disadvantages |
1 |
cohort |
1 |
eczema |
1 |
forced expiratory volume |
1 |
late-life depressive symptoms |
1 |
low birth weight |
1 |
lung |
1 |
macrosomia |
1 |
menopausal hormone therapy |
1 |
moderation |
1 |
prenatal depressive symptoms |
1 |
socioeconomic position |
1 |
time-varying mortality estimates |
1 |
vital capacity |
1 |